AUPH
AURINIA PHARMACE
Health Care·Biotechnology·CANADA
$15.78
MCap $2B
as of 2026-06-09
Total
B1w
Fund
A1w
Quant
C1w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-06-10
MIDOS SI
-0.12
Sentiment 66.7%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$15.78
Adaptive Mean
$15.82
-0.04 vs mean
Adaptive σ
0.16
MIDOS BB
$15.50 – $16.13
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-05-15
Composite Z
+0.95
ROE
65.0%
Z +1.35
Rev Gr
24.4%
Z -0.09
EPS Gr
5250.0%
Z +4.42
OPM Gr
52.4%
Z +0.00
FCF Yld
6.4%
Z +0.45
EPS Surp
28.2%
Z +0.18
EPS 3mo Δ
14.8%
Z +0.33
Fwd P/E
14.11
Z —
PEGY
0.00
Cheap (GARP)
Momentum (Risk-Adjusted Alpha)
as of 2026-06-10
Q3M
-1.72
Q6M
-1.27
Q12M
6.27
MA 30/100
1.035
Bullish (MA30 > MA100)
α (Jensen)
-0.1226
β (12M)
0.98
σ (12M)
0.455
Divergence — Fundamentals vs Momentum
Z Percentile
97%
Q Percentile
87%
Divergence
+10.0
Tier
ALIGNED
Fundamentals and momentum roughly in line.
Kirkpatrick RS & Persistence
RS
-9.0
RS Pctl
40%
RS Decile
D4
Persistence
1w
at grade B
Options / OI Analysis
No options or Williams data available for this ticker.